182 related articles for article (PubMed ID: 3484714)
61. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
62. The selective effects of dopamine and dobutamine on liver circulation in the dog.
Kinoshita G; Washizu M; Murata N; Kondo M; Matsukura Y; Washizu T; Motoyoshi S
J Vet Med Sci; 1995 Apr; 57(2):293-7. PubMed ID: 7492649
[TBL] [Abstract][Full Text] [Related]
63. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
64. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Navasa M; Chesta J; Bosch J; Rodés J
Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
[TBL] [Abstract][Full Text] [Related]
65. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
66. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
Conn HO; Grace ND; Bosch J; Groszmann RJ; Rodés J; Wright SC; Matloff DS; Garcia-Tsao G; Fisher RL; Navasa M
Hepatology; 1991 May; 13(5):902-12. PubMed ID: 2029994
[TBL] [Abstract][Full Text] [Related]
67. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.
Groszmann RJ; Bosch J; Grace ND; Conn HO; Garcia-Tsao G; Navasa M; Alberts J; Rodes J; Fischer R; Bermann M
Gastroenterology; 1990 Nov; 99(5):1401-7. PubMed ID: 2210246
[TBL] [Abstract][Full Text] [Related]
68. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
Bizer LS
Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
[TBL] [Abstract][Full Text] [Related]
69. Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension.
Mastaï R; Rocheleau B; Huet PM
Hepatology; 1989 Feb; 9(2):265-8. PubMed ID: 2492251
[TBL] [Abstract][Full Text] [Related]
70. Assessment of effects of propranolol on portal hemodynamics in cirrhosis by duplex ultrasonography.
Saigal S; Chawla Y; Dilawari JB
Indian J Gastroenterol; 1998 Apr; 17(2):51-2. PubMed ID: 9563219
[TBL] [Abstract][Full Text] [Related]
71. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511
[TBL] [Abstract][Full Text] [Related]
72. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
Barr JW; Lakin RC; Rösch J
Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
[TBL] [Abstract][Full Text] [Related]
73. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
Lee KC; Yang YY; Huang YT; Lee FY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2010 Apr; 119(1):45-55. PubMed ID: 20132096
[TBL] [Abstract][Full Text] [Related]
74. Effects of tham, isoprenaline and propranolol on blood flow and vascular resistances of the liver after in- and outflow occlusion. Relation with the splanchnic shock.
Stoitchcov E; Kawai T; Bleser F; Benichoux R
Eur Surg Res; 1976; 8(3):211-26. PubMed ID: 947759
[TBL] [Abstract][Full Text] [Related]
75. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
Calès P; Braillon A; Girod C; Lebrec D
J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
[TBL] [Abstract][Full Text] [Related]
76. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver.
Reichen J; Gerbes AL; Steiner MJ; Sägesser H; Clozel M
J Hepatol; 1998 Jun; 28(6):1020-30. PubMed ID: 9672179
[TBL] [Abstract][Full Text] [Related]
77. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
78. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
[TBL] [Abstract][Full Text] [Related]
79. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.
Sarin SK; Groszmann RJ; Mosca PG; Rojkind M; Stadecker MJ; Bhatnagar R; Reuben A; Dayal Y
J Clin Invest; 1991 Mar; 87(3):1032-6. PubMed ID: 1900306
[TBL] [Abstract][Full Text] [Related]
80. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
